SEC Form 4 · accession 0001624048-15-000006
Syneos Health, Inc. · SYNH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James T. Ogle
Director
Period of report
Dec 29, 2015
Accepted (ET)
Dec 31, 2015 · 7:47 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610950
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Dec 29, 2015 | M | 9,717 | $8.45 | A | 193,103 | D | |
| Class A Common StockF2 | Dec 29, 2015 | S | 9,717 | $50.062 | D | 183,386 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy Class A Common Stock)F3 | $8.45 | Dec 29, 2015 | M | 9,717 | D | — | Sep 28, 2020 | Class A Common Stock | 9,717 | 114,806 | D |
Explanation of responses
- F1The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4,2015.
- F2The price reported in column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.28, inclusive. The reporting person will provide to INC Research Holdings, Inc. (the "Issuer"), any security holder of the Issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3This option is fully vested.